[1] HOU SW, LI JH, YANG QC, et al.Dilemmas and Challenges on the Road to Ending the Acquired Immune Deficiency Syndrome Epidemic[J]. Medicine and Philosophy(公共卫生伦理), 2023, 44(20): 14-17. [2] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People’s Republic of China,Volume Ⅱ(中华人民共和国药典二部)[M]. Beijing: China Medical Science Press, 2020. [3] XIE SG, YAN LQ, WANG Y, et al.HPLC Determination of Three Specified Impurities in Efavirenz Tablets[J]. Drug Standards of China(中国药品标准), 2015, 16(5): 356-358. [4] MA CY, NING X, DUAN Q, et al.Study on the Mass Spectrometric Cleavage Pattern of Diphenhydramine Constituents Based on UPLC-Q-TOF-MS Technology[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2023, 20(12): 1326-1331. [5] CHEN ZQ, FU XD, ZHONG CP.Determination of Related Substances in the Bulk Oseltamivir by UPLC-Q-TOF-MS[J]. China Pharmaceuticals(中国药业), 2020, 29(17): 86-89. [6] LIN YY, PAN JR, SONG M, et al.Identification of the Related Substances of Eicosapentaenoic Acid Ethyl Ester Soft Capsules by LC-Q TOF/MS[J]. Journal of Pharmaceutical Analysis(药物分析杂志), 2023, 43(10): 1774-1783. [7] GUO CC, TAN HJ, LIU Q, et al.Determination of Trace Genotoxic Impurities in Nifedipine by Ultra High Performance Liquid Chromatography-Electrostatic Field Orbitrap High Resolution Mass Spectrometry[J]. Chinese Journal of Chromatography(色谱), 2022, 40(3): 262-272. [8] RUAN YD, WANG C, MENG XS, et al.Determination of Genotoxic Impurities in Irbesartan by High Performance Liquid Chromatography Triple Quadrupole/Composite Linear Ion Trap Mass Spectrometry[J]. Chinese Journal of Modern Applied Pharmacy(中国现代应用药学), 2025, 42(2): 260-264. [9] ICH. Impurities in New Drug Substances, Q3A(R2)[S]. ICH Harmonized Tripartite Guideline, 2006. [10] HE F, JIN JY, TAO XF.Research Progress on Drug Impurity Analysis[J]. Chemical Analysis and Meterage(化学分析计量), 2024, 33(8): 124-129. [11] LI SY, YUE QY, ZHANG YW, et al.Simultaneous Determination of 6 Kinds of N-nitrosamines Genotoxic Impurities in Losartan Potassium Raw Material and Its Formulations by GC-MS/MS[J]. China Pharmacy(中国药房), 2023, 34(15): 1380-1384. [12] LIU X, ZHU JJ, CHEN Z, et al.New Progress in the Control of Nitrosamine Impurities in Chemical Drugs[J]. Chinese Journal of Pharmaceuticals(中国医药工业杂志), 2024, 55(6): 770-776. [13] BECCARIA M, CABOOTER D.Current Developments in LC-MS for Pharmaceutical Analysis[J]. Analyst, 2020, 145(4): 1129-1157. [14] HAO G, HAN F, ZHOU G, et al.Research on the Related Substances of Adenosine Cobalt Amine for Injection Based on HPLC-QE-MS Technology[J]. Chinese Journal of Pharmacovigilance(中国药物警戒 ), 2023, 20(12): 1339-1445. [15] ZHANG Y, YAN ZK, WANG C, et al.Simultaneous Determination of Principal Components and Related Substances in Isocyclophosphamide APIs Based on UPLC-MS/MS Technique[J]. Drug Evaluation Research(药物评价研究), 2023, 46(12): 2535-2539. [16] DELVAUX A, RATHAHAO-PARIS E, ALVES S.Different Ion Mobility-Mass Spectrometry Coupling Techniques to Promote Metabolomics[J]. Mass Spectrometry Reviews, 2022, 41: 695-721. |